Comment on "Controlling long-term signaling: receptor dynamics determine attenuation and refractory behavior of the

Aryeh Warmflash1, Qixiang Zhang2, Ali H Brivanlou2

  • 1Center for Studies in Physics and Biology, The Rockefeller University, New York, NY 10065, USA. Laboratory of Molecular Vertebrate Embryology, The Rockefeller University, New York, NY 10065, USA. aryeh.warmflash@rice.edu.

Science Signaling
|September 25, 2014
PubMed

Insights

The transforming growth factor-β (TGF-β) pathway

Area of Science:

  • Cellular signaling pathways
  • Molecular biology
  • Developmental biology

Background:

  • The transforming growth factor-β (TGF-β) pathway is crucial for development and disease.
  • Signaling dynamics downstream of TGF-β ligand stimulation are not well understood.
  • Receptor dynamics influence Smad2/3 activity following TGF-β stimulation.

Discussion:

  • Cellular response to TGF-β involves a refractory period after receptor loss.
  • Transcriptional activity terminates independently of receptors and Smad2/3.
  • Smad2/3 activity does not accurately reflect transcriptional dynamics.

Key Insights:

  • TGF-β receptor dynamics control Smad2/3 activation.
  • Transcriptional signaling in the TGF-β pathway ends much earlier than Smad2/3 activity.
  • Downstream transcriptional events must be directly measured to understand signaling dynamics.

Outlook:

  • Further investigation into the mechanisms of receptor- and Smad2/3-independent transcriptional termination.
  • Exploring the implications of these findings for understanding TGF-β-related diseases.
  • Developing novel methods to directly measure transcriptional dynamics in real-time.

Related Concept Videos

TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.1K
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
15.0K
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
2.0K
Receptor Tyrosine Kinases01:26

Receptor Tyrosine Kinases

Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
15.4K
The Two-State Receptor Model01:29

The Two-State Receptor Model

The two-state receptor model explains a drug's interaction with receptors, such as G protein-coupled receptors and ligand-gated ion channels, to induce or inhibit a biological response. When no natural ligands are present, a receptor exists in an equilibrium of inactive (Ri) and active (Ra) conformations. The inactive form does not produce a response, while the active form generates a basal effect known as constitutive activity.
The binding affinity of a drug determines its interaction with...
3.5K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
4.6K